Navigation Links
Karolinska Development AB Announces Publication of Year End Report for 2009
Date:3/15/2010

STOCKHOLM, March 15, 2010 /PRNewswire/ -- Karolinska Development AB announces publication of its Year End Report 2009 on the company's website.

    Key events during the year:

    Group

    October - December 2009

    - Revenue increased by 8.3 % to 6.9 (6.4) MSEK.
    - Operating income amounted to -22.1 (-249.0) MSEK.
    - Profit after tax amounted to -19.4 (-246.4) MSEK.
    - Income per share before dilution amounted to -0.71 (-10.15) SEK.
    - Investments in portfolio companies during the period amounted to 27.1
      (65.0) MSEK.
    - Cashflow during the period 322.3 (55.5) MSEK.
    - Value of the total portfolio according to the International Private
      Equity and Venture Capital Valuation Board (IPEV Valuation Board)
      guidelines has at the balance sheet date been estimated at 1,512.3 MSEK
      compared to 1,321.8 MSEK as of December 31, 2008.

    January - December 2009

    - Revenue increased by 30.5 % to 30.3 (23.2) MSEK.
    - Operating income amounted to -13.5 (-70.5) MSEK.
    - Profit after tax amounted to -2.6 (-57.7) MSEK.
    - Income per share before dilution amounted to -0.10 (-2.34) SEK.
    - Investments in portfolio companies during the period amounted to 172.4
      (148.6) MSEK.
    - Cash flow during the period amounted to 204.8 (180.3) MSEK.

    Parent company

    January - December 2009

    - Revenue increased by 116.1 % to 6.7 (3.1) MSEK.
    - Operating loss amounted to -101.1 (-61.5) MSEK.

The entire report is available on http://www.karolinskadevelopment.com under Investors> Reports.

About Karolinska Development

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies. The portfolio includes a total of 19 potential first in class products. http://www.karolinskadevelopment.com

    Conny Bogentoft
    CEO Karolinska Development
    Tel: +46(0)706-68-61-43,
    e-mail: conny.bogentoft@karolinskadevelopment.com
    Karolinska Development AB (publ)
    Org.nr 556707-5048


SOURCE Karolinska Development AB

Back to top
'/>"/>
SOURCE Karolinska Development AB
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
2. 3 new honorary doctors at Karolinska Institutet
3. The Feinstein to collaborate with Swedens Karolinska Institute
4. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
5. Karolinska Development Invests in EvoStem Finland Oy
6. Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
7. Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing Portfolio
8. Michael J. Fox Receives Honorary Doctorate From Karolinska Institute
9. Michael J. Fox to be made honorary doctor at Karolinska Institutet
10. Isolation of a new gene family essential for early development
11. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology: